Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Morgan

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Neurology. Clinical Practice|March 1, 2017
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapyAlberto J Espay, Fernando L Pagan, Benjamin L Walter, et al.
Plos Genetics|December 2, 2008
Field-caught permethrin-resistant Anopheles gambiae overexpress CYP6P3, a P450 that metabolises pyrethroidsPie Müller, Emma Warr, Bradley J Stevenson, et al.
Journal of Parkinson'S Disease|October 8, 2015
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone EffectsDavid K Simon, Tanya Simuni, Jordan Elm, et al.
Cannabis and Cannabinoid Research|December 17, 2021
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor MicroenvironmentHesam Khodadadi, Évila Lopes Salles, Ahmet Alptekin, et al.
Parkinsonism & Related Disorders|December 27, 2014
Parkinson's disease severity and use of dopaminergic medicationsJohn Y Fang, Adriana Pérez, Chadwick W Christine, et al.
Neurology. Clinical Practice|August 15, 2018
What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registrySotirios A Parashos, Bastiaan R Bloem, Nina M Browner, et al.
Scientific Reports|February 15, 2018
Candidate-gene based GWAS identifies reproducible DNA markers for metabolic pyrethroid resistance from standing genetic variation in East African Anopheles gambiaeDavid Weetman, Craig S Wilding, Daniel E Neafsey, et al.
Eneuro|October 6, 2025
Rethinking Alzheimer's: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation ControlSahar Emami Naeini, Bidhan Bhandari, Breanna Hill, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2016
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like DiseaseManuj Ahuja, Navneet Ammal Kaidery, Lichuan Yang, et al.
International Journal of Molecular Sciences|November 9, 2024
Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer's DiseaseHesam Khodadadi, Évila Lopes Salles, Sahar Emami Naeini, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Neurology. Clinical Practice|March 1, 2017
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapyAlberto J Espay, Fernando L Pagan, Benjamin L Walter, et al.
Plos Genetics|December 2, 2008
Field-caught permethrin-resistant Anopheles gambiae overexpress CYP6P3, a P450 that metabolises pyrethroidsPie Müller, Emma Warr, Bradley J Stevenson, et al.
Journal of Parkinson'S Disease|October 8, 2015
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone EffectsDavid K Simon, Tanya Simuni, Jordan Elm, et al.
Cannabis and Cannabinoid Research|December 17, 2021
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor MicroenvironmentHesam Khodadadi, Évila Lopes Salles, Ahmet Alptekin, et al.
Parkinsonism & Related Disorders|December 27, 2014
Parkinson's disease severity and use of dopaminergic medicationsJohn Y Fang, Adriana Pérez, Chadwick W Christine, et al.
Neurology. Clinical Practice|August 15, 2018
What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registrySotirios A Parashos, Bastiaan R Bloem, Nina M Browner, et al.
Scientific Reports|February 15, 2018
Candidate-gene based GWAS identifies reproducible DNA markers for metabolic pyrethroid resistance from standing genetic variation in East African Anopheles gambiaeDavid Weetman, Craig S Wilding, Daniel E Neafsey, et al.
Eneuro|October 6, 2025
Rethinking Alzheimer's: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation ControlSahar Emami Naeini, Bidhan Bhandari, Breanna Hill, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2016
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like DiseaseManuj Ahuja, Navneet Ammal Kaidery, Lichuan Yang, et al.
International Journal of Molecular Sciences|November 9, 2024
Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer's DiseaseHesam Khodadadi, Évila Lopes Salles, Sahar Emami Naeini, et al.
Pageof 12